28 Capital LLC

About 28 Capita (Formerly known as Tiger Gene, which was seeded by Tiger Management) We specialize in unlocking high-potential technologies trapped in academia, partnering with leading scientists and institutions to turn cutting-edge research into breakthrough therapies 28 Capital is a life sciences venture fund dedicated to creating and building the next generation of transformative biotech companies. Through our unique investment model, we not only provide capital—we roll up our sleeves to help found, fund, and scale companies from day one. Our team brings deep scientific and operational expertise, helping entrepreneurs advance from concept to clinic with speed, precision, and purpose. At the heart of our work is a singular mission: to help founders realize their boldest visions and bring life-changing innovations to patients who need them most. At 28 Capital, we don’t just invest—we build.